El papel multifacético de p53 en la biología molecular del cáncer: ideas para el diagnóstico de precisión y avances terapéuticos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Ver abstracta en PubMed
Resumen
Este resumen es generado por máquina.La proteína p53, crucial para la estabilidad del genoma, actúa como supresor y promotor de tumores en el cáncer. La comprensión de sus funciones complejas y la orientación de las vías de p53 ofrece nuevas estrategias de precisión en oncología.
Área De La Ciencia
- Biología molecular
- En el campo de la oncología
- La genética
Sus Antecedentes
- La proteína p53 es un regulador crítico de la homeostasis celular y un supresor de tumores clave.
- La función deteriorada de p53 está implicada en varios cánceres, afectando el inicio del tumor, la progresión y la resistencia al tratamiento.
Objetivo Del Estudio
- Revisar las funciones multifacéticas de p53 en el cáncer, incluida su doble función como supresor y promotor.
- Para explorar la participación de p53 en vías no canónicas, microambiente tumoral, metabolismo y modulación inmune.
- Discutir las estrategias diagnósticas y terapéuticas emergentes dirigidas a la p53.
Principales Métodos
- Revisión de la literatura que integra los hallazgos recientes sobre la biología p53 y el cáncer.
- Análisis de las funciones canónicas y no canónicas de p53.
- Examen de los avances en el diagnóstico (biopsia líquida, IA) y las estrategias terapéuticas (pequeñas moléculas, edición de genes, inmunoterapia).
Principales Resultados
- p53 muestra actividades supresoras de tumores o promotoras oncogénicas dependientes del contexto.
- La p53 mutada puede obtener funciones pro-oncogénicas e influir en el microambiente tumoral y la evasión inmune.
- El estado de p53 afecta la eficacia de la inmunoterapia, en particular el bloqueo de PD- 1/ PD- L1.
Conclusiones
- p53 es un biomarcador fundamental y objetivo terapéutico en oncología.
- Los diagnósticos de precisión y las estrategias terapéuticas en evolución dirigidas a las vías p53 son prometedores para mejorar el tratamiento del cáncer.
- La integración de datos multiómicos y clínicos es clave para avanzar en la oncología de precisión centrada en p53.
Contact us Si estos videos no son relevantes.
Contact us Si estos videos no son relevantes.
Videos de Conceptos Relacionados
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Three of the best-understood negative regulators are p53, p21, and retinoblastoma protein (Rb). The regulatory roles of each of these proteins were discovered after faulty copies were found in cells with uncontrolled replication (i.e.,...
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...